| Hospice Of Western Michigan 989 Spaulding Se, Ada, MI, 49301 | |
| (616) 454-1426 |
News Archive
Merck & Co., Inc. today said it will vigorously appeal a Massachusetts federal court jury verdict concerning allegations that a former subsidiary of Schering-Plough Corporation, Warrick Pharmaceuticals, caused the Commonwealth of Massachusetts to overpay local pharmacists for prescriptions of albuterol. Merck and Schering-Plough merged in November 2009. Warrick ceased operations prior to the merger, in 2008.
The leaders of Anthem Blue Cross and Blue Shield's Medicaid business are hailing Governor Mike Pence's proposal to enhance the state's Healthy Indiana Plan (HIP).
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
› Verified 2 days ago
| Name | Hospice Of Western Michigan |
|---|---|
| Location | 989 Spaulding Se, Ada, Michigan |
| Hospice ID | 231510 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 400 |
News Archive
Merck & Co., Inc. today said it will vigorously appeal a Massachusetts federal court jury verdict concerning allegations that a former subsidiary of Schering-Plough Corporation, Warrick Pharmaceuticals, caused the Commonwealth of Massachusetts to overpay local pharmacists for prescriptions of albuterol. Merck and Schering-Plough merged in November 2009. Warrick ceased operations prior to the merger, in 2008.
The leaders of Anthem Blue Cross and Blue Shield's Medicaid business are hailing Governor Mike Pence's proposal to enhance the state's Healthy Indiana Plan (HIP).
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
› Verified 2 days ago
| NPI Number | 1508800418 |
| Organization Name | Hospice Of Michigan, Inc. |
| Address | 1260 Ekhart St Ne Grand Rapids, Michigan, 49503 |
| Phone Number | (616)454-1426 |
News Archive
Merck & Co., Inc. today said it will vigorously appeal a Massachusetts federal court jury verdict concerning allegations that a former subsidiary of Schering-Plough Corporation, Warrick Pharmaceuticals, caused the Commonwealth of Massachusetts to overpay local pharmacists for prescriptions of albuterol. Merck and Schering-Plough merged in November 2009. Warrick ceased operations prior to the merger, in 2008.
The leaders of Anthem Blue Cross and Blue Shield's Medicaid business are hailing Governor Mike Pence's proposal to enhance the state's Healthy Indiana Plan (HIP).
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.8 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 87.3 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.8 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Merck & Co., Inc. today said it will vigorously appeal a Massachusetts federal court jury verdict concerning allegations that a former subsidiary of Schering-Plough Corporation, Warrick Pharmaceuticals, caused the Commonwealth of Massachusetts to overpay local pharmacists for prescriptions of albuterol. Merck and Schering-Plough merged in November 2009. Warrick ceased operations prior to the merger, in 2008.
The leaders of Anthem Blue Cross and Blue Shield's Medicaid business are hailing Governor Mike Pence's proposal to enhance the state's Healthy Indiana Plan (HIP).
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
› Verified 2 days ago
| Home Health Aides | 13 |
| Counselors | 6 |
| Homemakers | 1 |
| Medical Social Workers | 5 |
| Physicians | 1.7 |
| Registered Nurses | 12.6 |
| Other Personnel | 12.3 |
| Total Employees | 51.6 |
|---|
News Archive
Merck & Co., Inc. today said it will vigorously appeal a Massachusetts federal court jury verdict concerning allegations that a former subsidiary of Schering-Plough Corporation, Warrick Pharmaceuticals, caused the Commonwealth of Massachusetts to overpay local pharmacists for prescriptions of albuterol. Merck and Schering-Plough merged in November 2009. Warrick ceased operations prior to the merger, in 2008.
The leaders of Anthem Blue Cross and Blue Shield's Medicaid business are hailing Governor Mike Pence's proposal to enhance the state's Healthy Indiana Plan (HIP).
NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
› Verified 2 days ago
| Hospice Of Western Michigan Location: 989 Spaulding Se, Ada, Michigan, 49301 Phone: (616) 454-1426 |